Cardio Diagnostics Holdings Inc (CDIO) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Cardio Diagnostics Holdings Inc   (NASDAQ: CDIO)


Cardio Diagnostics Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CDIO Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -28.29 %
Seq. Revenue Change 100 %
Revenue In Millions $0.01
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 610
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin



Observing second quarter 2026 results within In Vitro & In Vivo Diagnostic Substances industry 3 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
CDIO's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 156
Overall # 610

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2026)  




Other Gross Profit Margin Profitability Ratios
CDIO's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CDIO's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CDIO's Competitors
Gross Profit Margin Profit Margin for Cardio Diagnostics Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for CDIO's Customers

You may also want to know
CDIO's Annual Growth Rates CDIO's Profitability Ratios CDIO's Asset Turnover Ratio CDIO's Dividend Growth
CDIO's Roe CDIO's Valuation Ratios CDIO's Financial Strength Ratios CDIO's Gross Profit Growth
CDIO's Roa CDIO's Inventory Turnover Ratio CDIO's Growth Rates CDIO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.